Zoetis Inc. — Director's Dealing 2022

Feb 11, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Zoetis Inc. (ZTS)
CIK: 0001555280
Period of Report: 2022-02-08

Reporting Person: Ferran Astorga Jeannette (Executive Vice President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-08	Restricted Stock Unit	$	A	464	Acquired		Common Stock (464.0)	Direct
2022-02-08	Stock Option	$	A	1828	Acquired		Common Stock (1828.0)	Direct

Footnotes

F1: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

F3: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject toearlier vesting and settlement upon certain specific events.

F4: Not applicable.

F5: The RSUs vest as follows: 304.5056 RSUs will vest on September 30, 2023; 218.1953 RSUs will vest on February 10, 2024; and 464 RSUs will vest on February 8, 2025.

F6: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F7: 1,304 options granted September 30, 2020 at an exercise price of $165.37 per option; 925 options granted February 10, 2021 at an exercise price of $160.62 per option; and 1,828 options granted February 8, 2022 at an exercise price of $201.30 per option.

F8: Each option vests on the third anniversary of the date of grant.

F9: Each option expires on the tenth anniversary of the date of grant.